Event Details Exagen Fourth Quarter 2023 Financial Results Conference Call Mar 18, 2024 at 8:30 AM EDT Click here for Webcast Print Page Email Alerts RSS Feeds Investor Contacts × About Exagen ← Back Exagen Quality Lab Certifications Our Products ← Back AVISE CTD ← Back SLE & Connective Tissue Disease Test AVISE Lupus ← Back SLE Diagnostic Test AVISE SLE Monitor ← Back SLE Disease Monitoring Test AVISE SLE Prognostic ← Back SLE Prognostic Test AVISE APS ← Back Antiphospholipid Syndrome Test AVISE MTX ← Back Methotrexate Polyglutamate Measuring Test AVISE HCQ ← Back The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood AVISE Anti-CarP ← Back RA Diagnosis & Prognosis AVISE PC4d ← Back History of SLE Thrombosis Our People ← Back Leadership Board of Directors Careers Our Science ← Back CB-CAPs – Lupus Biomarkers Clinical Trials Research & Development Publications Business Development ← Back Business Development Partners ESG ← Back Corporate Governance ESG Report Investors Investor Relations ← Back Investor Overview Press Releases Events Presentations Annual Report SEC Filings Stock Information Investor FAQs Analyst Coverage Investor Contacts Email Alerts
Exagen Fourth Quarter 2023 Financial Results Conference Call Mar 18, 2024 at 8:30 AM EDT Click here for Webcast
